Biospecifics Technologies (BSTC) Tops Q2 EPS by 2c

August 9, 2016 5:10 PM EDT
Get Alerts BSTC Hot Sheet
Trade BSTC Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Biospecifics Technologies (NASDAQ: BSTC) reported Q2 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $6.2 million versus the consensus estimate of $6.25 million.

For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment